Publicacións en colaboración con investigadores/as de Universitat d'Alacant (17)

2023

  1. Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT)

    British Journal of Haematology, Vol. 203, Núm. 5, pp. 860-871

2022

  1. Cardiac protection induced by urocortin-2 enables the regulation of apoptosis and fibrosis after ischemia and reperfusion involving miR-29a modulation

    Molecular Therapy - Nucleic Acids, Vol. 27, pp. 838-853

2020

  1. ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort

    Revista Espanola de Patologia, Vol. 53, Núm. 3, pp. 140-148

  2. Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL)

    Lung Cancer, Vol. 150, pp. 62-69

  3. Spanish guidelines for diagnosis, management, treatment, and prevention of dress syndrome

    Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 4, pp. 229-253

2019

  1. DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: A retrospective study

    Journal of Biomedical Science, Vol. 26, Núm. 1

2017

  1. Timed Up and Go Test Performance as an Indicator of Fall History in Institutionalized Elderly

    Topics in Geriatric Rehabilitation, Vol. 33, Núm. 4, pp. 273-279

2016

  1. Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry

    Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250

2015

  1. A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881

  2. Epirubicin plus cyclophosphamide followed by docetaxel versus epirubicin plus docetaxel followed by capecitabine as adjuvant therapy for node-positive early breast cancer: Results from the GEICAM/2003-10 study

    Journal of Clinical Oncology, Vol. 33, Núm. 32, pp. 3788-3795

2014

  1. Importance of exercise in the control of metabolic and inflammatory parameters at the moment of onset in type 1 diabetic subjects

    Experimental and Clinical Endocrinology and Diabetes, Vol. 122, Núm. 6, pp. 334-340

  2. Response to circulatory death determination in uncontrolled organ donors: A panel viewpoint

    Annals of Emergency Medicine

2012

  1. Natural products from antarctic colonial ascidians of the genera Aplidium and Synoicum: Variability and defensive role

    Marine Drugs, Vol. 10, Núm. 8, pp. 1741-1764

2011

  1. Reliability of 4-m and 6-m walking speed tests in elderly people with cognitive impairment

    Archives of Gerontology and Geriatrics, Vol. 52, Núm. 2

2010

  1. Chemical defenses of tunicates of the genus Aplidium from the Weddell Sea (Antarctica)

    Polar Biology, Vol. 33, Núm. 10, pp. 1319-1329

2007

  1. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

    Lancet Oncology, Vol. 8, Núm. 3, pp. 219-225

2006

  1. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): Impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen

    Annals of Oncology, Vol. 17, Núm. 8, pp. 1205-1212